Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoporosis
•
Endocrinology
•
Primary Care
What treatment would you use in a patient with osteoporosis on denosumab for 10 years who develops ONJ at a site of an old implant?
Answer from: at Community Practice
A bone formative agent as teriparatide.
Comments
at Eldersburg Arthritis
Unless the patient has medicare and cannot afford ...
9315
Sign In
or
Register
to read more
16025
Related Questions
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
Would you start romosozumab in an active smoker?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
In a patient with a history of parathyroidectomy (due to primary hyperparathyroidism) with low T- scores and high risk of fractures, is there any contraindication to give teriparatide/Forteo if PTH is in normal range after surgery?
Is there an evidence-based consensus on CT-derived Hounsfield unit thresholds for opportunistic assessment of osteoporosis, and how should such measurements be applied when DXA results are inconclusive or do not meet diagnostic criteria?
In a patient with severe osteoporosis (T-score -3.9) and multiple vertebral fractures in the setting of multiple myeloma with bone involvement, would you consider adding an anabolic agent such as romosozumab or teriparatide despite concerns about osteosarcoma risk?
When interpreting bone density reports, are T-scores adjusted for different age brackets?
Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?
Do you use bone turnover markers to assess medical adherence in patients treated for osteoporosis?
Unless the patient has medicare and cannot afford ...